These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27574420)

  • 41. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS
    Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070
    [No Abstract]   [Full Text] [Related]  

  • 42. In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii.
    Thamlikitkul V; Tiengrim S
    Int J Antimicrob Agents; 2013 Sep; 42(3):284-5. PubMed ID: 23876336
    [No Abstract]   [Full Text] [Related]  

  • 43. Synergy and mechanism of action of α-mangostin and ceftazidime against ceftazidime-resistant Acinetobacter baumannii.
    Pimchan T; Maensiri D; Eumkeb G
    Lett Appl Microbiol; 2017 Oct; 65(4):285-291. PubMed ID: 28799218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
    Poirel L; Nordmann P
    Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain.
    Mugnier PD; Bindayna KM; Poirel L; Nordmann P
    J Antimicrob Chemother; 2009 May; 63(5):1071-3. PubMed ID: 19252183
    [No Abstract]   [Full Text] [Related]  

  • 46. In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.
    Tong W; Wang R; Chai D; Li Z; Pei F
    Int J Antimicrob Agents; 2006 Nov; 28(5):454-6. PubMed ID: 16987639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates.
    Kiratisin P; Apisarnthanarak A; Kaewdaeng S
    Int J Antimicrob Agents; 2010 Sep; 36(3):243-6. PubMed ID: 20541913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular mechanisms associated with nosocomial carbapenem-resistant Acinetobacter baumannii in Mexico.
    Alcántar-Curiel MD; García-Torres LF; González-Chávez MI; Morfín-Otero R; Gayosso-Vázquez C; Jarillo-Quijada MD; Fernández-Vázquez JL; Giono-Cerezo S; Rodríguez-Noriega E; Santos-Preciado JI
    Arch Med Res; 2014 Oct; 45(7):553-60. PubMed ID: 25450581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In Vitro Evaluation of Antimicrobial Peptide Tridecaptin M in Combination with Other Antibiotics against Multidrug Resistant
    Jangra M; Raka V; Nandanwar H
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32708842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals.
    Falagas ME; Skalidis T; Vardakas KZ; Voulgaris GL; Papanikolaou G; Legakis N;
    Int J Antimicrob Agents; 2018 Aug; 52(2):269-271. PubMed ID: 29559273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran.
    Sohrabi N; Farajnia S; Akhi MT; Nahaei MR; Naghili B; Peymani A; Amiri Z; Rezaee MA; Saeedi N
    Microb Drug Resist; 2012 Aug; 18(4):385-9. PubMed ID: 22352411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae.
    Clock SA; Tabibi S; Alba L; Kubin CJ; Whittier S; Saiman L
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):343-6. PubMed ID: 23601454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
    Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
    Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Strong and Nonspecific Synergistic Antibacterial Efficiency of Antibiotics Combined with Silver Nanoparticles at Very Low Concentrations Showing No Cytotoxic Effect.
    Panáček A; Smékalová M; Kilianová M; Prucek R; Bogdanová K; Večeřová R; Kolář M; Havrdová M; Płaza GA; Chojniak J; Zbořil R; Kvítek L
    Molecules; 2015 Dec; 21(1):E26. PubMed ID: 26729075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex.
    Akers KS; Barsoumian A; Beckius ML; Murray CK; Mende K
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):209-11. PubMed ID: 20466197
    [No Abstract]   [Full Text] [Related]  

  • 57. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
    Park YK; Jung SI; Park KH; Kim SH; Ko KS
    Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
    García-Quintanilla M; Caro-Vega JM; Pulido MR; Moreno-Martínez P; Pachón J; McConnell MJ
    Antimicrob Agents Chemother; 2016 Aug; 60(8):5076-9. PubMed ID: 27270288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [In vitro tigecycline and carbapenem susceptibilities of clinical Acinetobacter baumannii isolates].
    Nayman Alpat S; Aybey AD; Akşit F; Ozgüneş I; Kiremitçi A; Usluer G
    Mikrobiyol Bul; 2010 Oct; 44(4):641-5. PubMed ID: 21063976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.